We are live on ! Find out more
MC

Martin & Co Portfolio holdings

AUM $640M
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+2.71%
1 Year Est. Return
+23.57%
3 Year Est. Return
+67.79%
5 Year Est. Return
+76.4%
10 Year Est. Return
+289.06%
AUM
$324M
AUM Growth
+$9.86M
Cap. Flow
+$2.94M
Cap. Flow %
0.91%
Top 10 Hldgs %
24.36%
Holding
109
New
Increased
80
Reduced
24
Closed
2

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.85M
2
ATRI
Atrion Corp
ATRI
+$1.87M
3
CVX icon
Chevron
CVX
+$1.72M
4
QCOM icon
Qualcomm
QCOM
+$852K
5
MMSI icon
Merit Medical Systems
MMSI
+$202K

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.17%
2 Technology 11.44%
3 Healthcare 9.65%
4 Industrials 9.53%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYR icon
26
iShares US Real Estate ETF
IYR
$4.58B
$4.04M 1.25%
50,703
+1,760
+4% +$140K
MCK icon
27
McKesson
MCK
$104B
$3.97M 1.22%
24,115
+200
+0.8% +$30.3K
JPM icon
28
JPMorgan Chase
JPM
$951B
$3.84M 1.18%
41,995
+95
+0.2% +$8.2K
MRK icon
29
Merck
MRK
$366B
$3.77M 1.16%
61,693
+58
+0.1% +$3.53K
MCD icon
30
McDonald's
MCD
$188B
$3.76M 1.16%
24,552
-70
-0.3% -$10.1K
PG icon
31
Procter & Gamble
PG
$334B
$3.76M 1.16%
43,103
+42
+0.1% +$3.7K
IWR icon
32
iShares Russell Mid-Cap ETF
IWR
$57.1B
$3.74M 1.15%
77,800
-540
-0.7% -$25.6K
RTX icon
33
RTX Corp
RTX
$285B
$3.65M 1.13%
47,533
-8
-0% -$599
ORCL icon
34
Oracle
ORCL
$435B
$3.59M 1.11%
71,533
-20
-0% -$911
IJH icon
35
iShares Core S&P Mid-Cap ETF
IJH
$124B
$3.54M 1.09%
101,740
-3,225
-3% -$111K
IBB icon
36
iShares Biotechnology ETF
IBB
$10.5B
$3.4M 1.05%
32,910
+1,125
+4% +$111K
SCZ icon
37
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$3.38M 1.04%
58,509
+970
+2% +$55.3K
JNJ icon
38
Johnson & Johnson
JNJ
$646B
$3.12M 0.96%
23,607
+675
+3% +$86.1K
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
$3.12M 0.96%
48,920
+1,855
+4% +$117K
BA icon
40
Boeing
BA
$166B
$3.04M 0.94%
15,380
+45
+0.3% +$8.38K
ABT icon
41
Abbott
ABT
$195B
$3.04M 0.94%
62,485
-90
-0.1% -$4.07K
OMCL icon
42
Omnicell
OMCL
$1.51B
$2.84M 0.88%
65,990
+1,100
+2% +$45.7K
PEP icon
43
PepsiCo
PEP
$193B
$2.79M 0.86%
24,190
+40
+0.2% +$4.59K
GOOGL icon
44
Alphabet (Google) Class A
GOOGL
$4.24T
$2.76M 0.85%
59,360
-260
-0.4% -$12.2K
GS icon
45
Goldman Sachs
GS
$301B
$2.71M 0.84%
12,223
+20
+0.2% +$4.44K
JBSS icon
46
John B. Sanfilippo & Son
JBSS
$873M
$2.7M 0.83%
42,784
+2,722
+7% +$182K
T icon
47
AT&T
T
$178B
$2.65M 0.82%
92,970
+285
+0.3% +$8.4K
MMM icon
48
3M
MMM
$89.9B
$2.64M 0.81%
15,157
+6
+0% +$1K
IEO icon
49
iShares US Oil & Gas Exploration & Production ETF
IEO
$613M
$2.52M 0.78%
46,164
+25
+0.1% +$1.43K
XRT icon
50
State Street SPDR S&P Retail ETF
XRT
$322M
$2.37M 0.73%
58,150
+875
+2% +$36.4K

Similar funds

Martin & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Martin & Co held 109 positions worth $324M, up 3.1% from $315M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 1.8%. Martin & Co opened no new positions and exited 2, leaving the 109-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • Martin & Co added most to SpartanNash in Q2 2017, an estimated $1.19M increase.
  • Martin & Co's biggest Q2 2017 reduction was Medtronic, cutting an estimated $2.85M.
  • Martin & Co fully exited Atrion Corp in Q2 2017, selling an estimated $1.87M.
  • Martin & Co's ten largest holdings make up 24% of its $324M portfolio in Q2 2017.
  • Martin & Co opened 0 new positions and closed 2 in Q2 2017.
  • Martin & Co's portfolio value rose 3.1% quarter-over-quarter to $324M.

Based on Martin & Co's 13F filing for Q2 2017, filed 15 Aug 2017.